Physiologically-based pharmacokinetic
modeling for predicting drug-drug interactions
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Abstract

Dynamics of interactions between the drugs caffeine
and ciprofloxacin are predicted using
physiologically-based pharmacokinetic (PBPK)
modeling. Pharmacokinetic means the model
determines where the drugs are distributed in the
body over time. Physiologically-based means the
anatomy and physiology of the human body is
reflected in the structure and functioning of the
model. Multiple drugs can interact to increase or
decrease their beneficial and/or undesired effects.
This is important because some common substances,
such as caffeine in coffee and soft drinks, are actually
drugs that affect the body. By implementing the
model as a computer program, it is relatively
straightforward to perform “experiments” that would
be too costly, time-consuming, or even unethical, if
done on humans.

Results

What is a model?

• A model is a representation of something.
• A model is designed for a purpose.
• The model abstracts details that are not
important for its purpose.
• The model retains, exaggerates, or adds
details that are important for its purpose.
• There are usually many different ways
to model something.
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Drugs included in the model
Caffeine is a common
psychoactive stimulant found in
coffee, tea, soft drinks, and
energy drinks. Ciprofloxacin
slows the rate at which the body
eliminates caffeine.1

• A PBPK model was implemented for caffeine and ciprofloxacin
using the Mathematica program.
• Figures 1 and 2 show the concentrations of the drugs in each of the
compartments of the model. The different characteristics of each
compartment result in different drug concentrations.

A map and a globe are models of the Earth.
The map adds colors to show different
countries.
The globe exaggerates height to emphasize
mountains.
Neither is the same size as the Earth.
A map is easy to carry and can be scaled for
different purposes.
A globe can illustrate seasons, day and
night, and great circle routes.
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Figure 2: Concentration of ciprofloxacin in the model compartments. Initial
ciprofloxacin dose: 750 mg.

Ciprofloxacin is an antimicrobial
used to treat bacterial infections
by inhibiting DNA and protein
synthesis.2 It is also used by the
military to protect against
anthrax, a biological weapon.
Example human
(Charles Darwin)
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Figure 1: Concentration of caffeine in the model compartments. Initial caffeine dose:
100 mg.
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Example PBPK model

The block diagram (middle) is an
example of how a human (left) can be
modeled.
Organs important for the drugs under
study appear as compartments (blocks)
connected by blood flow (arrows).
Features not important for the drugs
under study are omitted or combined
into other (e.g., there is no brain).
The model is described using
mathematics (differential equations4).

Example metabolic pathways
(caffeine metabolism)

Drugs enter or leave the body:
• Drugs can enter through various portals
including intravenous or oral routes.
• Drugs circulate through the body via
blood flow, or accumulate in tissue.
• Drugs are eliminated by the kidney
(urine), the liver (metabolism), or the
lungs.
• Metabolism breaks down drugs using
enzymes (see example at right).
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• Ciprofloxacin inhibits the CYP1A2 enzyme.
• A model parameter KI is the dissociation constant of the enzymeinhibitor complex. A paper by Fuhr et al. provides a value for KI for
ciprofloxacin and CYP1A2: 0.18 mM.5
• A paper by Healy et al. gives the results of an experiment where
patients were given both caffeine and ciprofloxicin.1
• Figure 3 shows that when both drugs are present (blue, green), the
level of caffeine is higher than for caffeine alone (black) because
ciprofloxacin inhibits CYP1A2 from metabolizing caffeine.
• When Fuhr’s value for KI is used in the model (blue), the value for
t1/2 for caffeine, the time for the caffeine concentration to reach half
the original dose, does not match Healy’s experimental results.
• The PBPK model predicts a value of 7.5 μM for KI based on Healy’s
experiment (green).

Figure 3: Concentration of caffeine in the liver under different inhibition scenarios.
Initial caffeine dose: 100 mg. Initial ciprofloxacin dose: 750 mg.

